porphyria variegata
In South Africa
Can be traced bacck to one couple
port vine coloured urin (porphyrins in the urin) and sensitivity to sun -> skin blistering
autosomal dominant
vertical transmission
confirmed when male to male transmission
Pleiotropy
a single gene that gives rise to apparently unreleated effects
father of modern medical genetics
McKusick
who discovered the structure of genes
Watson & Crick
Rosalind Franklin
maurice wilkins
how many mitochondrial genes
37
Types of genetic disorders
Single-gene abnormalities
Chromosomal disorders
polygenic (multifactorial) disorders
Variable expressitivity
some individuals get more affected or different
(e.g. polycystic kidney disease)
Reduced penetrance
due to enviromental factors or modifying effects of other genes
Aneuploidy
Monosomy, Trisomy, Tetrasomy
Polyploidy
Tripleudy, Tetraploidy
Translocations
Reciprocal
Robertosoniam
Insertions
Pericentric
Paracentric
Disorders with the same phenotypefrom different genetic loci
genocopies
same phenotype from enviromental factors
phenocopy
compoud heterozygotes
two different mutations at the same locus
often people affected with recessive disorder have it except parents are related
holandric inheritance
Y-linked
daltonism, hairy ears
manifesting heterozygote
women for X-linked recessive but the mutant X is the active in most cells
incontinentia pigmenti
X-linked dominant disorder
heterozygous females can have a mosaic pattern of abnormal pigmentation
Usually lethal for male embryos
Paradoxical X-linked Inheritance
e.g. PCDH19
heterozygous state is harmful
or X-inactivision is disturbed
SHOX
short-stature homebox
in the pseudoautosomal region on the X
can be transmitted via cross-over to the Y
mutation causes the Leri-Wil dyschondrosteosis
Sex-influences diseases
gout
presenile baldness
hormone dependent
Prader-Willi syndrome
1 : 20 000
25-30% maternal uniparental disomy of chromosome 15
in 50-60% 2mb interstitial deletion
in 15% submicroscopic deletion
almost always on paternal chromosome
genes affected: SNRPN, or the genes for it’s expression (ICR, MKRN3, SNURF,snRNA …)
short stature, obesity, learning difficulty, hypogonadism
Angelman syndrome
1 : 15 000
paternal uniparental disomy or imprinting of the maternal chromosome
epilepsy, severe learning difficulties, ataxic gait and happy affect (happy puppy)
loss of only one gene: UBE3A
via mutation in UBE3A ligase gene or ICR
damage to nerve cells via ubiquitin
homoplasmy
all mitochondria are identical
-> no disease or severe
segmentaition genes
gap genes
pair-rule genes
segment polarity genes
HOX genes then are responsible for what is expressed
SHFM 1
split-hand-foot malformation
aka ectrodactyly
key gene is DLX5 or enhancer which is found in DYNC1I1
shows reduced or non-penetrance (not known why)
Protein signals for early development
fibroblast growth factors (FGFs) -> maintainance
BMPs (bone morphogenetic proteins) -> patterning in the mesoderm
get activated by ligand binding to their receptor
TGF-β
extracellular signaling polypeptides
33 members of cytokines
BMPs - acting through SMAD proteins
induced in cell cycle, cell migration, cell size, gastrulation, axis specification
Delta-nothc signaling
for axial deviation of presomitic mesoderm
precise temporally defined wave of cycling genes
dependent on cross-talk of Notch, Wnt and FGF pathways
SHH
Sonic hedgehog gene
induces cell proliferation
expressed in the notochord, brain and zone of polarizing activity of developing limbs (more -> more fingers)
it’s receptor is the PTCH
PTCH
receptor for SHH
inhibits the transmembrane protein Smo but when SHH binds the inhibition is off
activision of Smo leads to activation via GLI
when mutated -> Gorlin syndrome
Smo
inhibited by PTCH
induces signaling cascade with GLI
Holoprosencephaly
caused by mutation or deletion in SHH
incomplete cleavage of developing brain
most severe presents in cyclopia
Homebox Genes (HOX)
regulate expression of other transcription factors, cell adhesion proteins, cell movement, cell death
4 Hox gene clusters in humans with 39 genes overall
contain 180 bp
one HOX gene can compensate for the other
HOXB10 is more similar to HOXC10 than to HOXB11
hand-foot-genital syndrome
caused by mutation in HOXA13
shortening of the 1st and 5th digits
hypospadias and bicornuate uterus
synpolydactyly
mutation in HOXD13
insertion of additional digit
more severe in homozygotes
triplet-repeat expansion
Paired-Box genes (PAX)
130 aminoacid transcription regulator domain
9 PAX genes
5 of those associated with developmental abnormalities
Waardenburg syndrome type 1
PAX3 gene mutation
hearing loss, depigmentation of hair, skin or iris
PAX3 can also cause cancer (alveolar rhabdomyosarcoma)
Waardenburg syndrome type 2
mutation in MITF or SOX10
Renal-coloboma syndrome
mutation in PAX2
causes renal malformation and structural defects in parts of the eye (optic nerve, retina, …)
Aniridia
Mutation in PAX6
absense of the iris
key feature of the WADR syndrome -> gene deltetion including PAX6 on chromosome 11
Zinc Finger genes
These genes act aas transcription factors
bind to DNA via the “finger-like” loop projection of 4 amino acids that form a complex with a zinc ion
e.g. GLI3
Greig syndrome/cephalopolysyndactyly
large deletion or translocation involving GLI3
head, hand, foot abnormalities (polydactyly & syndactyly)
Pallister-Hall syndrome
caused by frameshift mutations in GLI3
polydactyly, hypothalmic hamartomata and imperforate anus
ZIC2 mutation
holoprosencephaly
ZIC3 mutation
lateralis defect
situs inversus
(situs solitus is normal)
RET-proto-oncogenes
encodes for cell surface tyrosine-kinase
gain-of-function mutation is present in thyroid cancer
loss-of-function in Hirschsprung disease
can also cause cancer (MEN2A, MEN28, medullary thyroid carcinoma)
FGF receptors
fibroblast growth factor receptors
for embryogenisis, cell division, migration and differentiation
has three extracellular immunoglobin like domains
two intracellular tyrosine kinase domains
Apert syndrome
mutation in FGFR2
-> needed for fusion of the 2nd and 3rd immunoglobin-like domain
premature fusion of cranial sutures, hand-foot abnormalities
Achondroplasia
mutation in FGFR3 -> replacement of glyine by arginine
most common genetic short stature
enlarged head and short proximal limbs
short-rib-polydactyly syndrome
autosomal recessive
mutation in DYNC2H1
complete mole
46 chromosomes due to fertilazation of an empty ovum by dispermy or one and endoreplication
all paternal
can undergo malignant change into invasive choriocarcinoma
-> treated with chemotherapy
Partial mole
69 chromosomes (triploidy)
23 maternal 46 paternal due to dispermy or endoreplication
almost no surviving rate of fetus
but only in rare cases malignant
X-chromosome inactivision
referred as lyonization
15-16 days after gestation (5000 cells)
achieved by methylation initiated by the XIST gene
In sex organs both X-genes are active
XIST
is responsible for inactivision of X-chromosome via methylation via RNA
does not inactivate the Pseudoautosomal region
X-chromosome mosaicsm
visible in women with X-linked ocular albinism or incontentia pigmenti
skewed X-inactivision
mutant chromosome is active
Sex development
from 6 weeks develops into female unless there is th etestis-determining factor from SRY gene (single exon)
SRY
triggers inhibition of a receptor for SOX9
XY DSD - Male pseudohermaphrodite
androgen insensitivity syndrome
mutation of androgen receptor gene on X-chromosome
partial (PAIS)
and complete (CAIS) develope breasts and female external genitalia but no internal
XX DSD - female pseudohermaphrodite
adrenal hyperplasia -> excess of androgen
testicular structures are present
hemoglobin structure
tetrameric
F: 2𝛼2𝛾 <1%
A: 2𝛼2β - 97%
A2: 2𝛼2𝛿 - 2-3%
𝛿 differs from β by 10 amino acids
𝛾 by 39
embryonic hemoglobin types
Gower 1
Gower 2
Portland 1
𝛼1 and 𝛼2
same amino acid sequence but different nucleotides
on chromosome 16
β is on 11
locus control region (lcr)
sequende of 6-20 kb 5’ to 𝜀 controls switching of β-like globin genes
similar for 𝛼
structural variants/disorders
point mutation
deletion
frameshift
insertion
chain termination
fusion chain (unequal crossing over)
HbS
on β chain point mutation
glutamic acid to valine
-> sickle cell disease
Hb Constant spring
on 𝛼 chain
chain termination leading to adding of 31 residues by a point mutation in stop codon
Hb Lepore/anti-Lepore
𝛿 and β chain fuse unequally together during meiosis because of sequence similarities
more genes -> anti-lepore
less genes -> lepore
methemoglobin
hemoglobin variant that is more stable in it’s reduced form
less oxygen affinity
Sickle-cell diesease
structural globin variants HbS
autosomal recessive inheritance
distorts shape of RBC under deoxygenated condition
-> less oxygen supply
Treatment consists of prophylactic penicillin (preventing sepsis) and use of hydroxyurea -> increase of level of HbF
20% HbF is needed
Sickle cell disease trait
heterozygous have small increased risk of sudden death
homozygous get sickle cell crisis …….
risk of pulmonary hypertension and heart failure
thalassemias
disorder of synthesis of globin chains
chronic myeloid leukemia
Philadelphia gene is translocated from gene 22 to 9
-> transfer of the Abelson (ABL) oncogene
-> fusion with BCR protein
Burkitt lymphoma
translocation of the c-MYC oncogene
to chromosome 14 on to a heavy chain immunoglobin locus -> overexpression
Gene amplification of oncogenes
N-MYC in 30% of neuroblastoma cases
MYC, N-MYC, L-MYC in lung carcinoma
in 20% of breast cancers ERBB2, MYC and cyclin D1 are amplificated
RAS and BRAF genes
important for RAS-MPK signaling pathway (cell division, …)
associated with neurofibromatosis type 1 and Noonan/cardio-facio-cutaneous/Costello group of syndromes
Retinoblastoma
follows autosomal inheritance but is recessive because it needs loss of one allele to occur
Loss of heterozygosity (LOH) due to recombination, conversion, deletion or point mutation
RB1 acting as a tumor suppressor gene
-> also associated with malignancies later in life (osteosarcoma, firbrosarcoma, …)
RB1
encodes for p105-Rb
p105-Rb forms a complex with E2F which regulates the proceding of cell cycle into S phase when p105-Rb is phosphorylated (inactivated)
no/or hyperphosphorylated RB1 -> cancer
Tp53
tumor suppressor gene
most frequently mutated of all known cancer genes
encodes for p53 which cooperates with activated Ras
Li-Fraumeni Syndrome
hereditary mutation of Tp53
causes adrenal carcinomas, sacromas and breast cancers
Loss of imprinting (LOI)
Loss of imprinting of the IGF2/H19 locus causes many tumors (e.g. Wilms tumor)
maternal or paternal allel is no longer silenced
IGF: insuline-like growth factor
hypermethylation of nucleotides
hypermethylation can lead to inactivation of tumor suppressor genes
CpG islands which are normally not methylated will, when methylated, change the chromosome structure -> silencing of genes
short telomeres
Ataxia telangiectasia
and other chromosome breakage disorders
(autosomal recessive)
Colorectal Cancer (CRC)
1 in 40 people
order of gene defects:
APC -> K-ras -> DCC, SMD4, SMD2 -> TP53
-> Metastasis
APC
mutation causes Familial adenomatous polyposis
RET
causes Multiple endocrine neoplasia type 2
BRCA1
breast-ovarian cancer
BRCA2
breast caner
NF1
Neofribromatosis 1
Familial adenomatous polyposis (FAP)
mutation in APC
developing multiple polyps of the large bowel which can carcinomatous change -> in 90% with FAP bowel cancer developes
Lynch syndrome
onset of colonic cancer in mid forties
inactivision of MSH2 caused by deletion in TACSTD1 (transcription exceeds into MSH2) (40%)
mismatch repair in MLH1 account for 50% of cases
instead of LOH it shows presence of new alleles called microsatallite instability (MSI)
Microsatellite instability (MSI)
present in 15% of colorectal cancers
high levels of MSI suggest a lynch syndrome related mutation
Breast cancer oncogenes
LOH: HER2, c-MYC and Ras, and cyclin D1 & E
amplification: EMSY (interacts with BRCA2)
tumor suppressors: RB, TP53, PTEN
susceptibility genes. BRCA1 and BRCA2
If Her2, estrogen receptors and progesteron receptors are all negative the tumor is not supported by hormones but are more agressive
Treatement of breast cancer
If hormone supported it’s Tamoxifen or Herceptin
If triple negative it’s PARP inhibitors
early onset familial cancers
for 40-50% of all familial breast cancer and carriers have 20-60% risk for ovarian cancer
for 30-40% of familial breast cancer
Males with BRCA2 mutation have 6% for breast cancer
Ovarian cancer
10% are due to single gene mutation (BRCA1, BRCA2, Lynch syndrome
Muteted gene is ATM
chromosome breakage syndrome
treatment for tuberculosis
Isoniazid
-> acetylation
acetylation
metabolism of drugs via adding an acetyl group into the molecule
done by action of N-Acetyltransferase
glucuronide conjugation
mostly in the liver
elimination of morphine and codeine
by action of G6PD
treatment of crohns disease
sulfonamide
and
diet
G6PD
enzyme in red blood cells
eliminates the treatment for malaria drug:
Primaquine
G6PD - deficiency
X-linked recessive
10% of afro-caribbean males affected
brighted ovum
absense of embryo
Noonan syndrome
missense mutation of PTPN11 (accounts for half of NS cases)
often gain-of-function
Neural tube defects
spina bifida or anencephaly
defective closure during first month of embryonic life
can happen with trisomy 13 and 18 (5-10%) as well as the rare autosomal recessive Meckel-Gruber syndrome
risk can be resuced by periconceptional multivitamin supplementation
when PDGFRA and PAX1 mutation in combi it’s 100%
prenatal testing for trisomy 21
Chorionic villi sampling 11-12 week
Amniocentesis 16 weeks
prenatal screeniong tests (triple and quatruple from mothers serum at 16 weeks)
hypomalanosis of ito
example of mosaicism diploidy/triploidy
skin skows Blaschko lines
learnig difficulties
Turner syndrome (45,X)
puffy extremities or neck webbing, short stature and ovarian failure
short stature due to SHOX gene on pseudoautosomal region
Estrogen replacement therapy
Fragile X syndrome
high fore head, large ears, long face, prominent jaw
learning difficulties, autistic features
female carriers can show facial features
locus is called FRAXA
-> CGG trinucleotide repeata
Other genes identified: FRAXE, FRAXF & FXTAS
Fraxa in fragile X
normal person has 1-50 CGG repeats
51-58 intermediate
59-200 premutation -> unstable
>200 full mutation
detection of fragile X
normal and premutation via PCR
full mutations via southern blotting
DiGeorge
due to deletion of 22q11
Phenylketuria
Autosomal recessive
deficiency of phenylalanine hydroxylase that converts phenylalanine into tyrosine
mutation in the PAH gene
phenylalanine is converted into phenylpyruvic acid and excreted
affeted individuals hav eblonde hair and blue eyes
treatment only with diet
children born to mothers with phenylketuria have a learing disability
Alkaptonuria
deficiency of homogentisic acid oxidase
-> homogentisic acid accumulates and is excreted via urine -> dark urine when exposed to air
mutation of HGD
dark ear wax or joints
Oculocutaneous Albinism
deficiency of tyrosinase
tyrosinase-negative (OCA type 1) and tyrosinase-positive (OCA type 2)
uncontrolled eye movements and lack of pigment
OCA type 1has mutation in tyrosinase gene
OCA type 2 in P-gene
Galactosemia
deficiency of the enzyme galactose 1-phosphate uridyl transferase which is needed for metabolism of galactose (dietary sugar)
newborns present vomiting, jaundice, lethargy, failure to thrive
untreated can lead to mental retardation
treatment includes feeding them with a milk substitute without lactose or galactose
von Gierke disease (GSD 1)
deficiency of glucose 6-phosphatase
-> needed for breakdown of liver glycogen to release glucose
newborns have enlarged liver and fast heart rate due to hypoglycemia
treatment by frequent feeding
Pompe disease (GSD 2)
deficiency of lysosomal enzyme ⍺-1,4-glucosidase
-> needed for breakdown of glycogen
newborn develope an enlarged heart in the first or second year cause by accumulation of glycogen in cardiac muscle
Congenital Adrenal Hyperplasia (CAH)
most common disease for ambiguous genitalia in female
90% have 21-Hydroxylase deficiency
25% have salt-losing form
less common:
-Desmolase deficiency -> pseudohermaphroditism
-5⍺-reductase daficiency -> under-masculinization
treated with cortisol and, when salt-losing form, with fludrocortisone
Familial Hypercholesterolemia
most common in AD in Western europe
individuals are at higher risk for premature coronary artery diesease
present in childhood with Xanthomata (deposition of lipid)
Low cholesterol uptake caused by abnormal synthesis/transport/binding of Low-density-lipid receptors
Is followed by dietary restrictions
another treatment is with statins -> less cholesterol production
Lysosomal storage diesease
not enough lysosomal enzymes for break down of macromolecules
when born children are normal but with more time there is an accumulatino of macromolecules
Mucopolysaccharidoses:
Hurler Syndrome (MPS 1)
Hunter Syndrome (MPS 2)
Mucopolysaccharidoses
defective degradation of carbohydrate side chain of acid mucopolysaccharide -> accumulation of sulfated polysaccharides -> features of CNS, skeleton, vascular system etc.
6 different types which are all autosomal recessive, except Hunter which is X-linkes
treated with enzyme replacement
or bone marrow transplantation
Hurler syndrome (MPS 1)
most severe MPS
hearing loss, curve of lower spine, poor growth, enlarged liver and spleen
urinary excretion of dermatan and heparan sulfate
Hunter syndrome
X-linked MPS
also excretion of dermatan and heparan
deficiency of the enzyme iduronate 2-sulfatase
-> needed fordegradation of glucosaminoglycans
inability to breakdown sphingolipids
Sphingolipidoses
inability of sphingolipid degradation
deposition of lipid and glycolipid in brain, liver and spleen
leads to progressive mental deterioration with seizures leading to death in childhood
16 types (Tay-Sachs and Gauchers disease)
Tay-Sachs disease
more common in Ashkenazi Jews
present by 6 months with poor feeding and floppiness
later with developmental regression and deteriorates, deafness, visual impairment
death occurs at age of 3
presence of the cherry-red spot in macula
reduced hexosaminidase A due to deficiency of the subunit β-hexosaminidase -> leads to accumulation of sphingolipid GM2 ganglioside
Menke disease
disorder of copper metabolism
presents with vomitting, seizures etc
characteristic is th lack of pigment in hair
serum copper and ceruloplasmin is low
gene codes for a copper transport protein
treating with exogenous copper
Wilson disease
copper metabolism disorder
presents in childhood over involuntary movements, abnormal tone, changes in behavior
Kayser-Fleischer rings around iris
abnormal liver function and also high levels of ccopper in liver
gene codes for copper ATPase from hepatocytes into bilary system
treated with D-penicilin
Mitochondrial Respiratory chain disease
symptoms are neurological signs: ataxia, dystonia, dementia, encephalopathy, seizures
and myopathic: weakness, cardiomyopathy, hypotonia
others are deafness, diabetes,
MERRF and MELAS
Myoclonic Epilepsy and Ragged red fiber disease (MERRF)
point mutation in lysine tRNA
Mitochondrial Encephalomyopathy, Lactic acidosis, and stroke-like Episodes (MELAS)
mutation in gene for leucine tRNA
Hutington disease
autosomal dominant with almost full penetrance
trinucleotide repeat of CAG
gene affected is HTT
up to 26 is normal
to 35 is mutable
39 is redeuced penetrance
40 and more is full disease with late onset …
juvenile is often at least 55 repeats
symtoms are chorea, memory impairment
in juvenile instead of chorea its ridgity
HMSN
40 different gene loci
1:3000
mostly autosomal dominant
type 1 is demyelinating and PMP22 (and in some cases MPZ)
is also more severe and earlier onset
type 2 is axonal MFN2 and NEFL
inverted champange bottle
type 4 is AR
CMTX1 is X linked dominant(5-10%)
SMA
on the SMN1 gene (always, mostly by deletion of exons 7-8) and SMN2 (the rest is point mutation)
carrier incidence is 1:50
type 1 most severe and earliest onset with 6 months
treatment ist spinraza and gene therapy
carrier determination is difficult because 4% of the population have two copies of SMN1
Motor Neurone Disease (MND) aka ALSaverage onset with 56
average onset with 56
SOD1 accounts for 20% of cases
expasion of GGGGCC hexanucleotide repeat
Neurofibromatosis 1
autosomal dominant with 100% penetrance
50% are due to de novo mutation
neurofibromin-1 is the gene -> tumor suppressor
Ras activity is up as fuck
large deletions are more affected
NF2
neurofibromin 2
deletion and point mutations
with deletions being milder than point mutations
Duchenne musclular dystrophie (DMD)
most common
1:3500 males
pseudohypertrophy of calves
x-linked recessive
mutation of dystrophin gene
2/3 deletions and others are duplications which affect the reading frame
often happens during paternal meiosis
dystrophin links intracellular actin with extracellular laminin in muscles
levels less than 3% are diagnostic
CK are increased
Myotonic dystrophy type 1
DMPK
CTG trinucleotide repeat
MD2
expasion of CCTG into first intron of ZNF9
-> its protein binds RNA
Cystic Fibrosis
AR
almost all males are infertile
mutation of CFTR to be precise of the subunit p.Phe508del
treatment with OKAMBI but only for p.Phe508del
Zuletzt geändertvor 2 Jahren